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Abstract 
Cardiovascular disease (CVD) morbidity and mortality is highly prevalent in patients with 
rheumatoid arthritis (RA) with debilitating effects for the individual as well as significant 
healthcare impact. Current evidence demonstrates that engaging in aerobic and resistance 
exercise (i.e. structured physical activity) can significantly improve patient-reported and 
clinical index-assessed outcomes in RA. In addition to this, engagement in exercise programs 
improves, in a dose-dependent manner, the risk of developing CVD as well as CVD 
symptoms and outcomes. The present narrative review uses evidence from systematic 
reviews and meta-analyses as well as controlled trials, to synthesize the current state-of-the-
art on the potential effects of aerobic and resistance exercise on CVD risk factors as well as 
on cardiac and vascular function and structure in people with RA. Where there is a lack of 
evidence in RA to explain potential mechanisms, relevant studies from the general population 
are also discussed and linked to RA. 
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Introduction 
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory condition characterized by 
symptoms, such as joint inflammation, pain and fatigue, contributing to functional disability 
and having detrimental effects on the quality of life of the people affected. RA is also 
characterized by systemic manifestations, including lung, skin, ocular and neurological 
involvement [1]. Most notably, over the last years it has been established that the incidence of 
cardiovascular disease (CVD) in the context of RA has increased [2]. A 2012 meta-analysis 
of observational studies that took onto consideration for analyses only the first CVD event 
during follow-up (data from 41.490 RA patients with no history of CVD prior to RA onset) 
revealed that the CVD incidence in RA is 48% (68% for myocardial infarction and 41% for 
cerebrovascular accidents); accurate estimates for heart failure were not available due to lack 
of data [3] but this is also thought to be increased in RA [4]. The potential contributors to the 
increased CVD risk in RA are multiple and may include increased prevalence of traditional 
CVD risk factors (such as obesity, dyslipidemia and hypertension) as well as the persistent 
inflammatory load that accompanies RA, and their sequelae, i.e. vascular dysfunction. As a 
result, considerable efforts have focused on developing recommendations to mitigate the 
detrimental effects of the increased CVD incidence in RA, such as the recent updated 
recommendations by European League Against Rheumatism (EULAR) [5]. 
Based on the accumulated evidence to date, increasing physical activity and/or 
engaging in aerobic and resistance exercise programs are effective interventions to 
significantly reduce CVD risk in RA [6, 7]. Given the high incidence of CVD in RA and the 
multiple different beneficial effects of exercise on CVD outcomes, the present review aims to 
describe the effects of exercise on CVD risk factors as well as the overall functional and 
structural cardiac and vascular physiological adaptations in RA. 
Search methodology 
This is a present narrative review which has not utilized a systematic review approach. 
However, we have still followed suggested evidence-based approaches to synthesize this 
review [8]. In specific, the studies to synthesize the arguments within the present review were 
predominantly based from systematic reviews and meta-analyses published in the Cochrane 
Library. Where relevant studies were not available in this data source, we have retrieved 
systematic reviews and meta-analyses, individual randomized and/or controlled trials (or in 
the absence of such studies, we retrieved epidemiological studies) from Medline/Pubmed. We 
have not used the Patient Intervention Comparison Outcome (PICO) tool, since the present 
review retrieved studies from the general population, population with different non-
communicable  diseases as well as rheumatic and musculoskeletal diseases (RMDs).  
 
Physical activity and exercise 
 
Physical activity is any bodily movement that produces contraction of the muscles and 
increases energy expenditure above resting levels.  Exercise is only part of a person’s overall 
physical activity levels, which needs to be structured and planned. There is some evidence in 
the general population and specific sub-populations to suggest that the beneficial effects of 
physical activity and exercise on various health outcomes are dose-dependent [9]. This means 
that the different intensities that can be applied through an exercise program can have 
different effects on human physiology (and thus the beneficial effects on different health 
outcomes) depending on whether the intensity will be light, moderate or vigorous. The 
present review focuses on the effects of exercise rather than overall physical activity in 
people with RA; it will also focus on the effects of aerobic and resistance types of exercise 
rather than any other training regimens while also reporting the intensity, where available 
and/or necessary.  
Aerobic and resistance type of exercise represents a significant stimulus within the 
human body.  In response to the increased physiological and metabolic demands imposed by 
aerobic and resistance exercise, the human body needs to acutely and rapidly adapt and alter 
resting physiological process, to meet the increased exercise-induced physiological demands. 
This process is characterized by marked changes, including increased oxygen uptake and 
oxygen delivery to the exercising muscles accompanied by increased cardiac and pulmonary 
function with the synergy of the vasculature. These repeated and acute changes result in long 
term physiological adaptations which are necessary to accommodate the requirements of 
repeated aerobic and resistance exercise training and are characterized by both functional and 
structural changes in different physiological systems, including the cardiovascular, metabolic 
and respiratory systems. The insisting presence of inflammatory load and functional 
disability in RA vs. the normal population may accelerate processes that lead to increased 
risk for comorbidities (e.g. CVD risk). However, it must be noted that exercise provides a 
stimulus for specific beneficial adaptation in humans, irrespective of the presence of a non-
communicable disease and/or condition. In support of this, the cardiorespiratory 
improvements seen in the healthy population vs. RA patients may be more pronounced after a 
certain training period for specific outcomes, however, research studies still demonstrate 
significant improvements in RA patients in both disease-related and patient-important 
outcomes [10].  
The numerous different beneficial health adaptations that take place in response to 
repeated engagement in aerobic and resistance exercise are now widely recognized. As a 
result, exercise engagement is now a most important part of public health strategies not only 
for the normal population but more importantly, in populations with non-communicable 
diseases, including RA. EULAR has now published specific recommendations for frontline 
healthcare practitioners promoting the inclusion of physical activity and exercise as part of 
routine clinical practice, aiming to improve the management of disease symptoms and reduce 
CVD risk in people with rheumatic and musculoskeletal diseases [11].  
 
Effects of exercise on atherosclerosis and inflammation  
 
Atherosclerosis is a process of accumulation of lipids and fibrous elements in the 
endothelium (tunica intima), predominantly in large coronary arteries [12]. Atherosclerosis is 
modulated by inflammatory processes throughout its development (endothelial activation, 
foam-cell formation and decreased cholesterol efflux, and plaque destabilization).  It has been 
hypothesized that the long-term inflammatory load in chronic inflammatory conditions, such 
as RA, may promote an accelerated atherosclerotic process and be associated with earlier 
sub-clinical or clinically overt manifestations and worse outcomes in such conditions [13]. 
Exercise seems to be able to partly reverse the following specific biological/physiological 
processes that associate with the atherosclerotic process. 
 
Improved lipid profile 
Research in non-RA populations suggests that exercise has beneficial effects on lipid profiles. 
An umbrella 2014 review – which included both meta-analyses and randomized controlled 
trials – on the effects of exercise on lipids, revealed significant exercise-induced beneficial 
effects on lowering total cholesterol levels in populations that did not receiving cholesterol-
lowering medication [14]. Results from another meta-analysis on adults with the metabolic 
syndrome (seven trials with 206 participants of which 128 in the exercise group) revealed 
that these effects seem to be predominantly due to aerobic endurance exercise increasing high 
density lipoprotein (HDL) rather than lowering low density lipoprotein (LDL) [15]. Exercise, 
particularly when maintained for more than four weeks, can also reduce triglyceride levels in 
males and females >18yrs in the general population [16, 17].  
 
Although there is a lack of equivalent large studies and meta-analyses on the effects of 
exercise on lipids specifically in RA, lipids have been investigated in relevant studies as a 
secondary outcome. Observational studies reveal that RA patients that engage in more 
physical activity and have better cardiorespiratory fitness levels – i.e. the ability of the 
cardiovascular and respiratory systems to supply oxygen to exercising muscles – have a 
better lipid profile (mainly higher HDL) compared to those RA patients who do not exercise 
[18, 19]. In line with these data, in a controlled trial of a six-month aerobic and strength 
exercise program vs. no exercise in people with RA, triglycerides were significantly reduced 
and HDL was significantly increased [20]. The specific physiological mechanisms for these 
exercise-induced benefits in RA are still unclear. However, possible mechanisms arise from 
work in other populations without history of CVD.  In specific, in response to exercise, 
skeletal muscles enhance their ability to increasingly utilize lipids, thereby reducing plasma 
lipid levels [21]. This is probably because exercise may increase lecithin-cholesterol 
acyltransferase, which is the enzyme responsible for ester transfer to HDL [22], which is 
mainly increased following exercise [23]. Moreover, exercise increases the activity of 
lipoprotein lipase, which hydrolyses triglycerides and also acts as a ligand/bridging factor for 
lipoprotein uptake [24]. It should be noted, however, that these effects may be depended on 
the intensity and frequency of exercise. Even in the general population, available data in this 
area are still immature and therefore, definitive conclusions cannot be drawn.   
 
Reduced oxidization of low-density lipoprotein and oxidative stress  
A necessary mechanism for the development of atherosclerosis is the oxidation of LDL, 
which then contributes to the formation of foam cells [12]. Although preliminary, currently 
available data indicate that, in normal and obese populations, LDL oxidation could be 
reduced in response to exercise thus, halting the progression of the atherosclerotic process 
[25, 26]. On the other hand, oxidative stress also contributes to the development of 
atherosclerosis and thus, to CVD. A 2017 meta-analysis (30 trials and 1346 healthy 
participants) revealed that increasing exercise participation reduces pro-oxidant parameters 
along with improving the body’s anti-oxidant capacity, thereby reducing the negative effects 
of oxidative stress [27]. Studies investigating the oxidative stress response to exercise in RA 
are scarce. A product of tyrosine nitration mediated by reactive oxygen species, 3-
nitrotyrosine, has been found to be decreased after three months of exercise training in RA 
patients [28]. These data, however, are preliminary and need to be confirmed in appropriately 
designed trials.  
 
Inflammation  
The inflammatory process requires key pro-inflammatory cytokines, namely interleukins 1 
and 6 (IL-1 and IL-6) and tumour necrosis factor alpha (TNFa), to work synergistically and 
cross-talk to initiate the acute phase response. In addition, the progression of atherosclerosis 
necessitates that inflammatory processes take place [12]. However, the phenotypes that 
characterize the kinetics of these key cytokines during inflammation and exercise, are 
significantly different. 
In healthy adults, IL-6 mRNA increases in a dose-dependent manner in response to 
exercise [29]. However, the overexpression of IL-6 during exercise is induced by muscle 
contraction and is not macrophage-driven, i.e. what is seen in the inflammatory processes. 
The actions of the overexpressed IL-6 in exercise and inflammation also differ. Rather than to 
initiate and progress the inflammatory response, the depleted intra-muscular energy during 
exercise results in the increase in IL-6 to act as a “trigger” for lipolysis and hepatic 
glycogenolysis and thus, to direct more energy into the energy-depleted exercising muscle 
[30]. The non-inflammatory phenotype of the exercise IL-6 induction is also supported by the 
fact that, in inflammation, IL-1 and TNFa are overexpressed, while during and post-exercise, 
the same cytokines remain suppressed. Furthermore, other cytokines with anti-inflammatory 
actions, such as soluble TNF receptor, interleukin 10 as well as IL-1 receptor antagonist also 
elevate during and post exercise [29]. It can thus be argued that overall, in non-RA 
populations, during and after an exercise bout/session, the human body creates an anti-
inflammatory environment.  
Adipocytes (cells of the adipose tissue) are a known trigger of biological pathways 
that promote the inflammatory response [31]. In line with this, increased adiposity (i.e. 
overweight and obese individuals) associates with higher inflammatory load compared to the 
general population; studies also reveal that inflammatory processes are activated early in 
adiposity expansion and progression [32]. A recent systematic review and meta-analysis of 




, investigating the effects 
of exercise vs. hypocaloric diet on adiposity, suggested that, in the absence of weight loss, 
exercise results in greater loss of visceral fat [33].  Reducing the size of adipocytes as a result 
of exercise, results in lower levels of inflammation, even in populations with non-
communicable, low-grade inflammatory diseases, such as diabetes [34]. It is therefore 
thought that in non-RA populations, the long-term anti-inflammatory effects of exercise are 
mainly mediated via the reduction in the size of adipocytes. 
Surprisingly, exercise and inflammatory load in RA has only been investigated as a 
secondary outcome with conflicting findings. For aerobic training, a single-arm pilot study 
utilizing a high-intensity walking intervention for 10 weeks resulted in significant reductions 
in erythrocyte sedimentation rate and number of swollen joints [35], however, results from 
relevant randomised controlled trials are not in line with this and did not observe similar 
reductions in the same parameters [36]. The conflicting findings with regards to aerobic 
training on inflammation (ESR or CRP levels) in RA are also evident in the 2009 Cochrane 
Library meta-analysis on exercise and RA [10]. In contrast, a systematic review and meta-
analysis on strength training, identified three studies (pulled results from 133 RA patients and 
125 RA controls) that investigated ESR as a secondary outcome, revealed significant 
reductions in this marker of inflammation; no data were available for other parameters of 
inflammatory load [37]. Importantly, none of the above trials have directly investigated the 
link between inflammation with CVD outcomes and therefore, the evidence of such 
associations/effects requires further investigation in RA.   
 
 
Effects of exercise on other classical CVD risk factors 
  
Hypertension 
Hypertension is highly prevalent in RA patients, however, in clinical practice is often 
underdiagnosed and undertreated [38, 39]. Elevated blood pressure represents a risk factor for 
CVD that can be reduced via exercise participation by a clinically significant magnitude in 
healthy adults [40]. Although medication can achieve higher reductions in blood pressure 
compared to exercise, a 2018 network meta-analysis of 391 randomized controlled trials, 
demonstrated a consistent reduction in systolic blood pressure, especially in hypertensive 
individuals [41].  
Studies investigating blood pressure responses to exercise do exist for RA. 
Observational studies suggest that higher levels of exercise and cardiorespiratory fitness 
associate with lower systolic blood pressure [18, 19]. A controlled study of combined aerobic 
and strength training vs. no exercise showed a significant reduction in both systolic and 
diastolic blood pressure [20]. However, the exact mechanisms for this phenomenon in this 
population have still to be identified. In general, the physiological mechanisms by which 
exercise can reduce blood pressure are multiple and have been studied in the general 
population but not RA; these include reduced peripheral vascular resistance, increased nitric 
oxide bioavailability as well as enhanced baroreceptor sensitivity [42].  
 
Insulin Resistance 
Insulin resistance is also highly prevalent in RA compared to non-RA controls, up to 31% 
[43]. Exercise is a cornerstone adjunct intervention for managing insulin resistance, a fact 
that has led the American Diabetes Association to publish a Position Statement promoting the 
use of exercise for – predominantly – managing type II diabetes [44]. The mechanisms that 
are thought to contribute to lower insulin resistance in response to exercise are via enhancing 
the translocation of the insulin-mediated glucose transporter type 4 (GLUT-4, an insulin 
regulated glucose transporter), that translocates from intracellular storage depots to the 
plasma membrane and T-tubules after exercise-induced muscle contraction. In healthy adults, 
the GLUT-4 translocation results in increased glucose uptake after the termination of an 
exercise session, and may last up to 24h [45]. In line with this, a recent Cochrane Library 
meta-analysis reveals that both aerobic and resistance training have statistically and clinically 
significantly effects on glycaemic control in type II diabetes [46]. These findings are partly 
corroborated in research on RA patients: higher physical activity and cardiorespiratory fitness 
levels associate with reduced insulin resistance in RA [18, 19] however, these findings have 
to be confirmed in appropriately designed, controlled trials.  
 
Obesity 
Obesity is now considered a real threat for public health and a strong risk factor associated 
with the development of non-communicable diseases, including CVD. Increased size of 
adipocytes (obesity phenotype) leads to insulin resistance as well as inflammation, which are 
important biological processes promoting disturbed physiological homeostasis [31]. Apart 
from energy storage, adipose tissue is now considered an endocrine and paracrine organ, 
secreting bioactive molecules called adipokines. Adipokines influence the inflammatory 
process by modulating aspects of the innate / adaptive immunity promoting a pro-
inflammatory state [47, 48], by enhancing the production of key pro-inflammatory cytokines, 
such as IL-1, IL-6 and TNFa, which are key molecules in the development and progression of 
both RA and CVD [49]. Due to the debilitating RA symptomatology which includes fatigue 
and functional disability, patients with RA tend to be more sedentary, which may be one of 
the main reasons why obesity and overweightness are more prevalent in this patient 
population compared to normal controls [47]. Studies in RA have demonstrated that obesity 
associates independently with CVD risk factors [50] and is a potential drive of the 
inflammatory state in RA [51]. As such it comes as no surprise that obesity may lead to a 
significantly higher 10-year CVD risk event probability in RA [52].  
Exercise may reduce adiposity, in a dose-dependent manner, however it must be 
noted that these findings derive from the general as well as overweight/obese populations. A 





investigating the effects of exercise vs. hypocaloric diet, revealed that in the absence of 
weight loss, increasing exercise can reduce visceral fat to a greater extend compared to 
dieting [33]. Another 2015 meta-analysis, in obese and overweight individuals, concluded 
that diet interventions require the contribution of exercise to elicit beneficial changes in body 
composition (i.e. reduced adiposity) and obesity-related metabolic biomarkers; the same 
study demonstrated that strength / resistance training in combination with a hypocaloric diet 
was more effective to improve body composition compared to other interventions [53].  
An overview of the exercise-induced physiological mechanisms on CVD risk factors 
and processes of atherosclerosis, appears in Figure 1. 
 
 




An important systemic manifestation and underdiagnosed condition in RA, is rheumatoid 
cachexia, a condition characterized by increased fat deposition and reduced muscle mass, 
while weight remains unchanged [54, 55]. Rheumatoid cachexia potentially develops due to 
two main reasons:  
 
a) Increased expression of TNFa that promotes proteolysis via the activation of nuclear 
factor-kappa B (NF- κB); NF-κB can result in the overexpression of the ubiquitin-proteasome 
system that in turn, can degrade muscle proteins [56]. Moreover, NF-κB can also promote the 
expression of inflammatory cytokines that directly or indirectly promote muscle-wasting 
while it can also inhibit processes of myogenic differentiation [57] which are necessary for 
the regeneration of atrophic muscles, such as those seen in RA. 
 
b) Physical inactivity which results in increased fat deposition and reduced muscle mass.  
 
This profound change in body composition seen in RA, may contribute to the progression of 
a CVD phenotype due to the increased fat deposition [55].  However, more research is 
required to establish these associations and/or effects as well as the exact prevalence of 
rheumatoid cachexia based on appropriate diagnostic criteria (53). It is worth noting, 
nevertheless, that the effects of rheumatoid cachexia (muscle wasting) may contribute to the 
lack of exercise in RA, further increasing the risk of CVD [55, 58].  
 
 
Effects of exercise on cardiac and vascular structure and function 
 
Aerobic and resistance exercise training results in beneficial changes in cardiac and vascular 
structure and function. The current knowledge around these beneficial exercise-induced 
changes derives from areas of sport science (i.e. effects of exercise on athletes). In contrast, 
studies in RA have investigated the effects of RA on different cardiac/vascular structural and 
functional changes as part of the disease presence and progression, with only one study 
available in relation to exercise in RA.  
 
Cardiac Function and Structure 
The exercise-induced cardiac adaptations can be characterized as structural, functional as 
well as related to the electrical activity of the heart. These beneficial aerobic and resistance 
effects of exercise have led to the use of the term “athlete’s heart” which indicates the 
marked changes in the heart of athletes when compared to non-active and/or sedentary 
counterparts. A 2013 meta-analysis of 92 prospective studies in athletes (84 on 
echocardiography and 17 on magnetic resonance imaging) on exercise-induced cardiac 
changes, revealed larger left ventricular structures in endurance and resistance-trained 
athletes [59]. Relevant studies in RA are currently missing and therefore, relevant 
conclusions cannot be drawn for this population.  
RA develops at a later age in life, which coincides with unfavourable structural and 
functional changes in the heart. In addition to this, the increased prevalence of CVD risk 
factors seen in RA, places this population at an increased risk for CVD morbidity and 
mortality. Ageing per se results in changes in cardiac structure (left ventricular enlargement 
to compensate the loss of cardiomyocytes, atrial hypertrophy and dilatation) and function 
(electrical dysfunction, reduced left ventricular diastolic function and indirect systolic 
dysfunction through decreased myocardial contractility) [60]. However, involvement in 
exercise has been found to associate with slowing down the ageing-related effects of cardiac 
dysfunction. Veteran endurance athletes demonstrate larger absolute and indexed right and 
left ventricular end-systolic and end-diastolic volumes, stroke volume as well as wall 
thickness compared to age-matched non-athletic controls [61]. The biological mechanisms 
characterizing pathological cardiac hypertrophy, a potential sign of compromised heart 
function leading to heart failure, are different from those induced by exercise; the latter 
changes are associated with enhanced cardiac function. A summary of the exercise-induced 
mechanisms in the hearts’ structure and function, appears in Figure 2.   
The molecular mechanisms for the observed exercise-induced cardiac phenotypes are 
mediated via the insulin-growth factor 1 (IGF1), the phosphoinositide 3 kinase (PI3K), and 
protein kinase B (Akt) pathway (Figure 2). Inhibition of the IGF1-PI3K-Akt pathway is 
detrimental to the function of the myocardium and may lead to the development of CVD. 
Early research into the athlete’s-heart revealed that IGF1 and PI3K activation associate with 
cardiac hypertrophy (non-pathological phenotype) in athletes [62]. The activation of PI3K 
also seems to mediate molecular cardiac adaptations via targeting the Akt (serine / threonine 
kinase), and predominantly the Akt1 isoform. Akt activation phosphorylates cytosolic, 
mitochondrial and nuclear targets that regulate the observed exercise-induced myocardial 
growth [63].    
  Studies examining the heart in RA also exist, however these are mainly observational 
studies comparing the heart structure function and structure differentiation between RA 
patients and non-RA controls. Patients with RA who are asymptomatic for CVD, demonstrate 
a compromised cardiac structure and function, when different cardiac – predominantly 
echocardiographic – outcomes have been investigated. Perhaps the most common 
phenomenon of compromised cardiac function in RA is diastolic dysfunction. Left 
ventricular diastolic dysfunction is found in 45% of RA patients with no CVD symptoms 
compared to a significantly lower 20% of non-RA controls [64], an observation also 
confirmed by a meta-analysis of 25 studies in 1614 RA patients [65]. Although, RA-related 
pathways, such as RA duration and IL-6 have been independently associated with diastolic 
dysfunction in RA [66], more research is required to determine the exact physiological 
mechanisms around these observations. Other structural cardiac outcomes also seem to be 
compromised in RA. In specific, recent meta-analyses revealed increased absolute and 
indexed left ventricular mass in RA patients [16 case control studies, [67]] and that, almost 
half of CVD asymptomatic RA patients (10 case-control studies) demonstrate marked 
valvular (nodules, stenosis, calcification and insufficiency) as well as pericardial effusion 
[68]. 
Finally, an area of research which is worth mentioning, is cardiac strain. Cardiac 
strain is an echocardiographic method for measuring segmental as well as global myocardial 
deformation (i.e. during the cardiac cycle). Although still far from been realized within 
clinical practice for diagnostic purposes, the evaluation of systolic strains and strain rates is 
now emerging as an important assessment for non-communicable diseases that are 
characterized by impaired myocardial function. In RA, disease activity and severity associate 
with greater left ventricle strain as well as left ventricular longitudinal strain [69, 70]. These 
findings may hold promise in the identification of subclinical cardiac morbidity which may 
be present despite normal left ventricular ejection fraction, however, more research is 
required on this area.  
 
***** Figure 2 around here ***** 
 
 
Unfortunately, no studies exist to date, that have investigated the associations and/or effects 
of exercise on cardiac function and structure in RA.  Nevertheless, cardiorespiratory fitness – 
a very significant beneficial outcome that requires, at least in the short term, functional 
cardiac adaptations – significantly increases in response to exercise in RA with direct 
significant beneficial effects in patient- and clinically-important outcomes, such as functional 
ability and fatigue [10, 71]. The identification of the cardiac structural and functional 
mechanisms that determine these changes in RA is necessary, thus necessitating more 
research in this field. This can provide greater insights on how the exercise-induced 
adaptations can reverse and/or mitigate the adverse cardiac effects seen in RA.  
 
Vascular function and structure  
 
The endothelium which is considered a very active organ, lines the entire cardiovascular 
system and is involved in multiple functions, including inflammation, angiogenesis and 
regulation of vascular tone. The long-term term inflammatory load of RA, is thought to affect 
these processes, thereby, promoting an unfavourable CVD phenotype [72]. However, the 
most recent, yet now dated,  systematic review on the effects of RA on vascular function (93 
studies, of which 27 longitudinal and 57 cross-sectional) does not provide definite 
conclusions about the associations and effects of persistent inflammation on different aspects 
of vascular function and structure in RA [73]. In general, disturbed vascular homeostasis, 
which is a silent process (i.e. characterized by a lack of physical symptoms) contributes to the 
development of and is thought to precede atherosclerosis. Nitric oxide is the main 
endothelium-derived regulator of vascular homeostasis; reduced nitric oxide synthesis and 
bioavailability promotes dysfunction via loss of basal vasodilator tone, enhanced blood cell 
migration and raised local chemokine and/or cytokine release, thereby promoting 
atherosclerosis [74].  
The vasculature responds rapidly to aerobic and resistance exercise-induced stimuli, 
playing a key role in the acute and chronic beneficial adaptations of exercise. The vascular 
network undergoes significant functional (acute effects) as well as structural (long-term 
effects) adaptations to adapt to the exercise-induced metabolic demands, which are 
characterized by significant variations in intensity-dependent hemodynamic stress. In line 
with this notion, it is thought that vascular shear stress, which is elevated in response to 
exercise to supply active cardiac and skeletal muscles with blood to meet the increased 
metabolic demands, seems to be the prime physiological signal that promotes exercise-
induced vascular adaptations [75].   
Exercise-induced functional adaptations in the vasculature precede structural changes 
however, both materialize in response to exercise in both the normal population as well as in 
patients with RA. Nitric oxide is a major vasodilator regulating vascular homeostasis and a 
molecule that is highly responsive to exercise-induce stimuli. It is also one of the most 
important molecular adaptations to exercise training that takes place both in the skeletal as 
well as the coronary vasculature. A systematic review and meta-analysis of 51 randomized 
controlled trials in healthy adults revealed that aerobic exercise, resistance exercise as well as 
the combination of these two, all significantly increase the bioavailability of nitric oxide, 
while dose-dependent (i.e. intensity dependent) adaptations take place in response to aerobic 
exercise training [75]. Nitric oxide is produced by endothelial nitric oxide synthase in the 
endothelium, and exercise activates endothelial nitric oxide synthase via Akt phosphorylation 
[76] and stimulates the expression of neuronal and endothelial nitric oxide synthases in 
skeletal muscle [49]. In addition, exercise can acutely increase endothelial progenitor cells, 
responsible for endothelial repair, as well as promote endothelial growth and angiogenesis 
[77]. Finally, shear stress also results in the overexpression of prostacyclin, an effective 
vasodilator [49]. These pathways suggest that exercise acts as a stimulus in healthy adults for 
significant events to take place within the vasculature, potentially contributing to the 
significant benefits that are seen in response to acute and long-term vascular adaptations 
(Figure 1).  
In line with this, the only available study that investigated the effects of exercise on 
endothelial function in RA, revealed that significant adaptations occur at both three and six 
months of combined aerobic and resistance training at both micro- (small vessels) and macro- 
(large arteries) levels [78]. It is also worth noting that results from two different controlled 
trials, revealed that although exercise results in beneficial changes in the expression of nitric 
oxide, no such changes are seen upon treatment with anti-TNF agents in RA [79]. Apart from 
this established mechanism, that may occur early with exercise training, studies comparing 
long-term athletes with non-exercising controls  report also that exercise results in structural 
changes of the endothelium, such as expansion in the density of arterioles/capillaries and 
improved microvascular collateral formation [80]. These adaptations are thought to follow 
the aforementioned nitric-oxide alterations, however the exact timeframe by which they take 
place is currently unknown.  
 
Summary  
Aerobic and resistance exercise elicits significant beneficial effects on established CVD risk 
factors and results in beneficial adaptations in the function and structure of the cardiac and 
vascular systems. Although many studies in non-RA adults have established this and pointed 
to several potential explanatory biological mechanisms, the exact pathways in a high-grade, 
chronic inflammatory environment, such as this of RA, and the time-frame and exercise 
dosage (intensity, frequency and duration) of aerobic and resistance exercise training remain 
under-investigated and unclear in the RA population.  Yet, these collective beneficial effects 
of exercise on CVD outcomes as well as other patient- and clinically-important outcomes 
should be actively considered all along the patient journey, by public health to primary care 
physicians and rheumatology specialists and their multidisciplinary care teams. Maintenance 
of sufficient exercise dosage to achieve health-enhancing effects potentially requires a 
lifestyle change in this population and thus, collaborative partnerships are required with 
expert behavioural scientists and practitioners that understand the different barriers of people 
with RA, to tackle the lack of engagement in exercise in this patient population.  Much more 
research is needed in this field, all the way from basic research and appropriately designed 
clinical trials to implementation research in order to advance this field and position correctly 
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Figure 1: Overall mechanisms of exercise on CVD outcomes 
 
Note:  indicates increased exercise-induced expression,  indicates reduced exercise-induced expression. 
Abbreviations: tumor necrosis factor alpha – TNFa, interleukin 1 beta – IL-1b, C-reactive protein – CRP, low-
density lipoprotein – LDL, Prostacyclin – PG I2, endothelial nitric oxide synthase – eNOS, nitric oxide – NO, 
interleukin 10 – IL-10, interleukin 6 – IL-6, soluble tumor necrosis factor receptors – sTNFr, interleukin 1 





 Figure 2. Exercise-induced functional and structural adaptations 
 
Abbreviations: insulin-growth factor 1 – IGF1, phosphoinositide 3 kinase – PI3K, and protein kinase b – Akt. 
 
